Dear All, I like to invite you to join two exciting Epigenetic Talks by the world leading scientists Yi Zhang and Bing Ren on Oct 23 and Nov 4, respectively, at Academia Sinica. Bing Ren UCSD Regulation of the 3D Genome 11 am, Nov 4, 2014 B1 Auditorium, IMB, Academia Sinica Dr. Bing Ren, Member of Ludwig […]
Epigenetic Talks Bing Ren Read More »
由 sufang 在 日, 11/02/2014 – 11:09 發表 Pre-published Cancer Metabolism Notes Youtube https://www.youtube.com/watch?v=nFelWNxpdWk Genomic alterations in cancersmutations (300,000; > 20,000 genes)epithelial : 50-100; leukemia: 20amplifications (3000)deletions (thousands)translocations (fusions: 7000)epigenetic changes (extensive)Drivers : hundred, 90% loss of functionsInter-and intra-tumor heterogeneity (Charles Sweton)< 1/2 mutated or amplified genes expressed Two more oncometabolic papers from Harvard Groups: Nature (2011). Functional
2014年10月30日癌症研究國際研討會: 從基礎科學到臨床應用 由 sufang 在 四, 10/30/2014 – 09:42 發表 Pre-published cancer of excellence International symposium on cancer research Meeting 二期癌症研究計劃 癌症研究國際研討會 衛福部 首頁: http://scr.nhri.org.tw/index.jsp 台大醫院國際會議中心 301會議室 (77240109) 衛福部 許明能次長致辭 龔院長致辭 1. 張元吉教授: Combination targeted therapy in advanced lung cancer 2. 陳慶士教授: Fighting an organized crime network in pancreatic cancer: tumor
2014年10月30日癌症研究國際研討會: 從基礎科學到臨床應用 Read More »
由 sufang 在 二, 10/28/2014 – 14:27 發表 Pre-published EBV EBV associated gastric cancer IDO1 Lymphoproliferative disorders PLoS Pathog. 2013;9(5):e1003341. doi: 10.1371/journal.ppat.1003341. Epub 2013 May 9.Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. Strong MJ1, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong
EBV associated malignancies and IDO1 expression Read More »
由 sufang 在 日, 10/26/2014 – 09:14 發表 Pre-published IDO1 要找IHC能用的抗體，可以上 The human protein atlas網站．像以HNSC IDO1而言，就有三個選擇 HPA023072, HPA023149, HPA027772. 素芳提議染100例oral cancer檢體、或是補染40對T/N samples。 2014/10/28: TDO2也有抗體 Antibody HPA039611. HNSC TDO2. IDO2 則似乎沒有收錄．
10/14 (二) 蕭醫師來訪建議. Read More »
由 sufang 在 日, 10/26/2014 – 09:25 發表 Pre-published IDO1 TDO2 Time: 10:00~11:30 October 24, 2014 (Fri) Topic: IDO pathways in pathogenic inflammation and immune escape in cancer Speaker: George C. Prendergast, PhD (CV download) Professor, President & CEO, Lankenau Institute for Medical Research Editor-in-Chief, Cancer Research (他說兩大要件: (1) Pathological relevalence (2) Translational relevance. 若是一堆western
Dr. George Prendergast’s visit Read More »
EBV Infection-II 由 ingrid 在 三, 04/23/2014 – 11:41 發表 EBV and KSHV EBV infection NP460hTERT OKB2 #1由 ingrid 在 一, 04/28/2014 – 17:16 發表。 雖然細胞培養在不對的培養液中，但病毒綠光感染率仍有13%(w/TGF-b1)。 #2由 ingrid 在 一, 05/05/2014 – 14:56 發表。 WB結果顯示測不到Rta及Zta蛋白質的表現 #3由 EVKVLIN 在 二, 04/29/2014 – 09:14 發表。 恭喜, 但不懂.. 這次不是改正成養在正確的medium中了嗎? 妳是說infection前細胞都是養在DF-K的意思嗎? Infection 時 細胞density仍然小於70%嗎? #4由 mmiiee 在 二, 04/29/2014
Dear All, On behalf of the organization committee, I like to invite you to join 2014 CMU Mini-symposium on Transcription, Epigenetics and Stem Cell to be held at China Medical University at Taichung from 12:30 to 5:30 pm on Oct 20 of 2014. We are very pleased to have three world leading scientists Yi Zhang, Hongkui Deng
2014/10/20 CMU Mini-symposium on Transcription, Epigenetics and Stem Cell Read More »
大家好, 延後至11/04的報告題目是.. Metabolic enzyme expression highlights a key role for MTHFD2and the mitochondrial folate pathway in cancer The Link欣蕙
2014-11-04 Journal Club Paper Read More »
由 natsumi 在 四, 10/09/2014 – 16:14 發表 Cholangiocarcinoma FGFR3 IHC #1由 natsumi 在 四, 10/09/2014 – 16:30 發表。PROTOCOL Immunohistochemistry Staining (for paraffin-embedded sections) 1. Deparaffinize ¯ immerse slide in xylene for 7 min ´ 3 times (reused ~5 times). ¯ immerse slide in 100% ethanol for 3 min ´ 2 times (new). ¯ immerse
Immunohistochemistry of FGFR3 in oral and bladder tissue microarray Read More »